| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |